搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 天
Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch
Alnylam Pharmaceuticals has strong growth potential, particularly with Amvuttra for ATTR-CM. Read why ALNY stock justifies a ...
clinicalpainadvisor.com
3 天
Pre-Exposure Prophylaxis Use Increased in Recent Years
PrEP use increased between 2013 and 2023, according to study findings published in the Journal of the American Medical Association.
Medscape
5 天
Neurologists Lack Awareness of Steroid Toxicity
There is a lack of understanding among neurologists on how to balance the risks for and benefits of corticosteroids in ...
6 天
EU CHMP recommends AstraZeneca and Ionis’ Wainzua for ATTRv-PN
AstraZeneca and Ionis are collaborating on the commercialisation of the drug following a December 2021 global agreement.
pharmaphorum
6 天
AZ, Ionis get CHMP backing for ATTR polyneuropathy drug
AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...
PharmTech
6 天
AstraZeneca’s Polyneuropathy Treatment Recommended for EU Approval
Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.
EuropaWire
7 天
Wainzua Receives EU Recommendation for Treating Hereditary Amyloidosis, Offering New ...
AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...
7 天
Ionis Pharmaceuticals announces CHMP recommends approval for Wainzua
Ionis Pharmaceuticals (IONS) announced that Ionis’ and AstraZeneca’s (AZN) Wainzua has been recommended for approval by the ...
7 天
AstraZeneca polyneuropathy treatment recommended for EU approval
(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat ...
7 天
AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin ...
AstraZeneca Plc. (AZN.L, AZN) and Ionis' Wainzua (eplontersen) has been recommended for approval by the Committee for Medicinal ...
7 天
AstraZeneca's nerve damage treatment recommended for approval in EU
Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU.
STAT
10 天
Potential competition for RSV prophylactic Beyfortus
New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈